Free Trial
LON:CRDA

Croda International (CRDA) Share Price, News & Analysis

Croda International logo
GBX 3,609 +29.00 (+0.81%)
(As of 11:54 AM ET)

About Croda International Stock (LON:CRDA)

Key Stats

Today's Range
3,524
3,609
50-Day Range
3,604
4,321
52-Week Range
3,524
5,154
Volume
617,472 shs
Average Volume
534,786 shs
Market Capitalization
£5.04 billion
P/E Ratio
3,084.62
Dividend Yield
3.02%
Price Target
GBX 4,900
Consensus Rating
Moderate Buy

Company Overview

Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations. In addition, the company offers crop protection and seed enhancement related solutions. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.

Croda International Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
44th Percentile Overall Score

CRDA MarketRank™: 

Croda International scored higher than 44% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Croda International has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Croda International has received no research coverage in the past 90 days.

  • Read more about Croda International's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Croda International is 3,084.62, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 128.94.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Croda International is 3,084.62, which means that it is trading at a more expensive P/E ratio than the Basic Materials sector average P/E ratio of about 108.31.

  • Price to Earnings Growth Ratio

    Croda International has a PEG Ratio of 1.40. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Croda International has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CRDA.
  • Dividend Yield

    Croda International pays a meaningful dividend of 2.69%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Croda International does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Croda International is 9,316.24%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Croda International's dividend.
  • Short Interest

    There is no current short interest data available for CRDA.
  • News Sentiment

    Croda International has a news sentiment score of -0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.37 average news sentiment score of Basic Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Croda International this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Croda International insiders have bought more of their company's stock than they have sold. Specifically, they have bought £434.06 in company stock and sold GBX 0 in company stock.

  • Percentage Held by Insiders

    Only 0.93% of the stock of Croda International is held by insiders.

  • Percentage Held by Institutions

    68.18% of the stock of Croda International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Croda International's insider trading history.
Receive CRDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Croda International and its competitors with MarketBeat's FREE daily newsletter.

CRDA Stock News Headlines

Croda International Q3 Group Sales Rise; Confirms FY24 Outlook
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
See More Headlines

CRDA Stock Analysis - Frequently Asked Questions

Croda International's stock was trading at GBX 5,050 on January 1st, 2024. Since then, CRDA stock has decreased by 28.5% and is now trading at GBX 3,609.
View the best growth stocks for 2024 here
.

Croda International Plc (LON:CRDA) announced its earnings results on Wednesday, July, 25th. The company reported $100.20 EPS for the quarter, beating analysts' consensus estimates of $100.00 by $0.20. Croda International had a trailing twelve-month return on equity of 7.03% and a net margin of 9.98%.

Shares of CRDA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Croda International investors own include Barclays (BARC), HSBC (HSBA), GSK (GSK), Lloyds Banking Group (LLOY), AbbVie (ABBV), AstraZeneca (AZN) and Alibaba Group (BABA).

Company Calendar

Last Earnings
7/25/2018
Ex-Dividend for 10/8 Dividend
9/05/2024
Dividend Payable
10/08/2024
Today
11/14/2024

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
5,852
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 4,900
High Stock Price Target
GBX 5,300
Low Stock Price Target
GBX 4,200
Potential Upside/Downside
+35.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
£162.70 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.63 billion
Cash Flow
GBX 290.79 per share
Book Value
GBX 1,664 per share

Miscellaneous

Free Float
N/A
Market Cap
£5.04 billion
Optionable
Not Optionable
Beta
0.74
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (LON:CRDA) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners